摘要:
The present invention provides, among other things, methods of removing virus from a sample, compositions treated in accordance with such methods, a composition comprising a naturally-occurring non- infectious HIV comprising gp120, a composition comprising a solid support matrix to which is attached a cyanovirin or a conjugate thereof, a conjugate comprising a cyanovirin coupled to an anti-cyanovirin antibody or at least one effector component, a composition comprising such a conjugate, methods of inhibiting prophylactically or therapeutically a viral infection of a host, methods of inducing an immune response to a virus in an animal, and a matrix-anchored anti-cyanovirin antibody.
摘要:
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which include a leukotoxin polypeptide fused to one or more selected GnRH multimers which comprise at least one repeating GnRH decapeptide sequence, or at least one repeating unit of a sequence corresponding to at least one epitope of a selected GnRH molecule. Under the invention, the selected GnRH sequences may all be the same, or may correspond to different derivatives, analogues, variants or epitopes of GnRH so long as the GnRH sequences are capable of eliciting an immune response. The leukotoxin functions to increase the immunogenicity of the GnRH multimers fused thereto.
摘要:
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which include a leukotoxin polypeptide fused to one or more selected GnRH multimers which comprise at least one repeating GnRH decapeptide sequence, or at least one repeating unit of a sequence corresponding to at least one epitope of a selected GnRH molecule. Under the invention, the selected GnRH sequences may all be the same, or may correspond to different derivatives, analogues, variants or epitopes of GnRH so long as the GnRH sequences are capable of eliciting an immune response. The leukotoxin functions to increase the immunogenicity of the GnRH multimers fused thereto.
摘要:
The present invention provides, among other things, methods of removing virus from a sample, compositions treated in accordance with such methods, a composition comprising a naturally-occurring non- infectious HIV comprising gp120, a composition comprising a solid support matrix to which is attached a cyanovirin or a conjugate thereof, a conjugate comprising a cyanovirin coupled to an anti-cyanovirin antibody or at least one effector component, a composition comprising such a conjugate, methods of inhibiting prophylactically or therapeutically a viral infection of a host, methods of inducing an immune response to a virus in an animal, and a matrix-anchored anti-cyanovirin antibody.
摘要:
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected GnRH multimer which consists essentially of at least one repeating GnRH decapepetide sequence, or at least one repeating unit of a sequence corresponding to at least one epitope of a selected GnRH molecule. Under the invention, the selected GnRH sequences may all be the same, or may correspond to different derivatives, analogues, variants or epitopes of GnRH so long as the GnRH sequences are capable of eliciting an immune response. The leukotoxin functions to increase the immunogenicity of the GnRH multimer fused thereto.